Login to Your Account



Other News To Note


Wednesday, November 20, 2013
• Alliqua Inc., of Langhorne, Pa., inked a licensing agreement with Celgene Cellular Therapeutics, a subsidiary of Celgene Corp., of Summit, N.J., for development and marketing rights to wound care products Biovance and Extracellular Matrix (ECM).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription